SMAD2 and pancreatic neoplasm: In addition, the RT-PCR and Western blot analyses also revealed that the TFCP2 overexpression significantly promoted the transcription of the SMAD2 gene in pancreatic cancer cells (Fig. 7d and e; Supplementary Fig. 1e).